We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Joint Replacement Surgery in the Obese Has Low Complication Rates

By HospiMedica International staff writers
Posted on 19 Aug 2010
A new study has found that joint replacement surgery complication rates in obese patients are low, supporting those in favor of doing the procedures even in the heaviest patients; hospital stays, however, were found to be longer in the obese.

Researchers at the University of Michigan (Ann Arbor, USA) and the Hospital for Special Surgery (HSS; New York, NY, USA) conducted a review of 211 knee and 147 hip replacement surgeries performed between January 1, 2008, and December 31, 2009, by a single surgeon at the HSS. More...
Complication rates were examined in those with a body mass index (BMI) of 30 kg/m2 or higher; a total of 136 (72%) of the knee procedures and 49 (34%) of the hip procedures involved patients who were obese; overall, 56% of the replacement procedures involved obese patients. The patients were examined for pulmonary embolism (PE), deep vein thrombosis (DVT), wound drainage, blood transfusions, infections, and length of stay in the hospital.

The researchers found that there were only four cases of PE's and DVT's, and they were all in the knee replacement group. There were six cases of wound drainage in the knee group and five in the hip group, and there was one superficial infection in the knee group, with none in the hip group. The only area where a difference was noted in the obese patient group was the length of hospital stay, which averaged 5.2 days in the knee group and 4.2 days in the hip group, compared to the average hospital stay for these replacement procedures of just 3 days. The results of the study were presented as a poster session at the National Medical Association 2010 annual convention and scientific assembly, held during July-August 2010, in Orlando (FL, USA).

"There was really a surprisingly high incidence of obesity in the joint replacement patients,” said coauthor Denise Asafu-Adjei, a medical student at the University of Michigan. "But complications were not particularly high. . . . We expected that, across the board, they would be pretty high.”

"I have almost the same profile; half the people I operate on in this category are considered obese. But we do them routinely and we have just great results, almost indistinguishable from small people,” commented William Long, M.D., a surgeon who performs joint replacement procedures at Good Samaritan Hospital (Los Angeles, CA, USA), who said the results of the HSS study dovetail with his own experience with obese patients. "Now we know the best thing we can do to save their lives is fix them. If you can get them walking again, you're going to save their lives.”

Related Links:
University of Michigan
Hospital for Special Surgery


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.